Glycation in diabetic neuropathy: Characteristics, consequences, causes, and therapeutic options

This publication has 79 references indexed in Scilit:

• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Reduction of advanced glycation end‐product (AGE) levels in nervous tissue proteins of diabetic Lewis rats following islet transplants is related to different durations of poor metabolic control
  European Journal of Neuroscience, 1998
• The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions
  Journal of Biological Chemistry, 1996
• Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins
  Protein Journal, 1995
• Effects of acute, subacute, and chronic diabetes on carbohydrate and energy metabolism in rat sciatic nerve. Relation to mechanisms of peripheral neuropathy
  Diabetes, 1995
• Relationship Between Glycemic Control and Collagen-Linked Advanced Glycosylation End Products in Type I Diabetes
  Diabetes Care, 1993
• Glucose transporters of rat peripheral nerve. Differential expression of GLUT1 gene by Schwann cells and perineural cells in vivo and in vitro
  Diabetes, 1992
• The O2−-forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function
  Biochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics, 1986
• Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats
  Diabetes, 1983
• The carbohydrate moiety in hemoglobin A1C is present in the ring form
  FEBS Letters, 1981